PARIS, France – July 2017: Coordinated by the French Monitoring Centre for Drugs and Drug Addiction (OFDT) in France, in collaboration with four other institutes and universities in the Czech Republic, the Netherlands, Poland, and the United Kingdom, the findings of the I-TREND project show that new psychoactive substances (NPS) are being sold under different brand names and at varying levels of purity without users being aware. Whereas NPS sold via online shops to the United Kingdom generally consisted of a high purity and conformed with the labelling on the packaging, NPS sold in France frequently consisted of a lower purity and in the Netherlands, as well in Poland, often contained an entirely different set of substances as those outlined on the label.

As reported in the 2017 World Drug Report, countries such as Chile and Colombia in South America have also observed that NPS belonging to the NBOMe series were being either sold, or referred to, as “LSD”, and that users may not be aware that they are consuming NBOMe compounds.

For more information, please see:

Newsletter of the French Monitoring Centre for Drugs and Drug Addiction (OFDT) – http://ofdt.systalium.eu/lettre/?lettre=69&contact=3486#ws4

Report of Workstream 4 “Monitoring of substance content” – https://www.ofdt.fr/BDD/publications/docs/I-TREND/I-TREND_WS4_Final_Report.pdf

French Monitoring Centre for Drugs and Drug Addiction (OFDT) report on “Tendencies” – https://en.ofdt.fr/BDD/publications/docs/eftaacwc.pdf

“Market Analysis of Synthetic Drugs” of the World Drug Report 2017 – https://www.unodc.org/wdr2017/field/Booklet_4_ATSNPS.pdf